Literature DB >> 32986351

Investigations of a Possible Role of SNPs in KAI1 Gene on Its Down-Regulation in Breast Cancer.

Haitham Kussaibi1, Khaled R Alkharsah2.   

Abstract

OBJECTIVE: KAI1 (CD82) is a metastasis suppressor gene known to be down-regulated in carcinomas of breast, prostate and many other organs. The mechanism of KAI1 down-regulation is complex and not well understood. Here, we investigate the role of 8 SNPs (not previously studied) in KAI1 gene that could influence its expression in tumor tissue samples of breast cancer patients from the Eastern province of Saudi Arabia.
METHODS: Single nucleotide polymorphisms (SNPs) in KAI1 gene were selected from the NCBI website (dbSNP) and were then filtered for those SNPs causing stop codon mutations (rs139889503 and rs150533529) or nonsynonymous mutation in the 5'-UTR (rs11541048, rs77359459, rs115500759, rs182579675, rs200238062, and rs372733853). SNPs genotyping was performed using TaqMan SNP Genotyping Assay and the results were correlated with KAI1 protein expression profile by immunohistochemistry (IHC) on formalin-fixed paraffin-embedded (FFPE) samples of breast cancer and control none-neoplastic tissues.
RESULTS: KAI1 expression by IHC was observed in all none-neoplastic breast tissue samples and only in 35% out of the 59 breast cancer tissue samples. None of the samples was homozygous for the stop codon allele A in the SNP rs139889503 or allele T in the SNP rs150533529. The SNPs in the 5-UTR, rs11541048, rs115500759, and rs182579675, were only present in the homozygous state for the G and C alleles respectively in both cancer and control samples. The other SNPs in the 5'-UTR (rs77359459, rs200238062, and rs372733853) had no significant difference in the allele distribution between KAI1 expressing or none-expressing tissue samples.
CONCLUSION: Our findings showed no significant effect of the studied SNPs on down-regulation of KAI1 expression.<br />.

Entities:  

Keywords:  KAI1 down-regulation; KAI1 expression by immunohistochemistry; KAI1 gene loss of function; SNPs in KAI1 gene

Mesh:

Substances:

Year:  2020        PMID: 32986351      PMCID: PMC7779433          DOI: 10.31557/APJCP.2020.21.9.2549

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  29 in total

Review 1.  CD82 metastasis suppressor gene: a potential target for new therapeutics?

Authors:  Hélène Tonoli; J Carl Barrett
Journal:  Trends Mol Med       Date:  2005-11-03       Impact factor: 11.951

2.  Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.

Authors:  Sucharita Bandyopadhyay; Rui Zhan; Asok Chaudhuri; Misako Watabe; Sudha K Pai; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Yukio Takano; Ken Saito; Mary E Pauza; Sunao Hayashi; Ying Wang; Sonia Mohinta; Tomoyuki Mashimo; Megumi Iiizumi; Eiji Furuta; Kounosuke Watabe
Journal:  Nat Med       Date:  2006-07-23       Impact factor: 53.440

3.  High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.

Authors:  Katsuhiro Uzawa; Kanae Ono; Hiroyoshi Suzuki; Chihaya Tanaka; Takashi Yakushiji; Nobuharu Yamamoto; Hidetaka Yokoe; Hideki Tanzawa
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

4.  Lack of germ line changes in KISS1 and KAI1 genes in sporadic head and neck cancer patients of Pakistani origin.

Authors:  M Nazir; M R Kayani; Faraz Arshad Malik; Nosheen Masood; Mahmood Akhtar Kayani
Journal:  Asian Pac J Cancer Prev       Date:  2011

5.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.

Authors:  J T Dong; P W Lamb; C W Rinker-Schaeffer; J Vukanovic; T Ichikawa; J T Isaacs; J C Barrett
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

6.  Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.

Authors:  Stefania Scarpino; Enrico Duranti; Simona Giglio; Arianna Di Napoli; Dino Galafate; Donatella Del Bufalo; Marianna Desideri; Fabio Socciarelli; Antonella Stoppacciaro; Luigi Ruco
Journal:  Thyroid       Date:  2013-08-27       Impact factor: 6.568

7.  Role of KAI1/CD82 polymorphisms in colon cancer risk in Han Chinese population.

Authors:  Zhen-Bin Ma; Kun Li; Jian Wang; Guang-Hong Guo
Journal:  Med Oncol       Date:  2013-07-20       Impact factor: 3.064

8.  The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.

Authors:  Yien Che Tsai; Arnulfo Mendoza; Jennifer M Mariano; Ming Zhou; Zlatka Kostova; Bo Chen; Timothy Veenstra; Stephen M Hewitt; Lee J Helman; Chand Khanna; Allan M Weissman
Journal:  Nat Med       Date:  2007-11-25       Impact factor: 53.440

9.  Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion.

Authors:  Faraz Arshad Malik; Andrew J Sanders; Mahmood A Kayani; Wen G Jiang
Journal:  Cancer Genomics Proteomics       Date:  2009 Jul-Aug       Impact factor: 4.069

10.  Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.

Authors:  W U Shiwu; Yu Lan; Song Wenqing; Zhou Lei; Tao Yisheng
Journal:  Arch Iran Med       Date:  2012-11       Impact factor: 1.354

View more
  1 in total

1.  Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.

Authors:  Kelly Pedrozo Ferreira; Bruna Cristine de Almeida; Laura Gonzalez Dos Anjos; Glauco Baiocchi; Fernando Augusto Soares; Rafael Malagoli Rocha; Edmund Chada Baracat; Andrey Senos Dobroff; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.